IL122077A0 - Epi-inositol compositions for the treatment of CNS disorders - Google Patents
Epi-inositol compositions for the treatment of CNS disordersInfo
- Publication number
- IL122077A0 IL122077A0 IL12207797A IL12207797A IL122077A0 IL 122077 A0 IL122077 A0 IL 122077A0 IL 12207797 A IL12207797 A IL 12207797A IL 12207797 A IL12207797 A IL 12207797A IL 122077 A0 IL122077 A0 IL 122077A0
- Authority
- IL
- Israel
- Prior art keywords
- epi
- inositol
- compositions
- treatment
- cns disorders
- Prior art date
Links
- 208000015114 central nervous system disease Diseases 0.000 title 1
- CDAISMWEOUEBRE-NIPYSYMMSA-N epi-inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](O)[C@H]1O CDAISMWEOUEBRE-NIPYSYMMSA-N 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL12207797A IL122077A0 (en) | 1997-10-30 | 1997-10-30 | Epi-inositol compositions for the treatment of CNS disorders |
| PCT/IL1998/000523 WO1999022723A1 (en) | 1997-10-30 | 1998-10-29 | Epi-inositol compositions for the treatment of cns disorders |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL12207797A IL122077A0 (en) | 1997-10-30 | 1997-10-30 | Epi-inositol compositions for the treatment of CNS disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL122077A0 true IL122077A0 (en) | 1998-03-10 |
Family
ID=11070798
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12207797A IL122077A0 (en) | 1997-10-30 | 1997-10-30 | Epi-inositol compositions for the treatment of CNS disorders |
Country Status (2)
| Country | Link |
|---|---|
| IL (1) | IL122077A0 (en) |
| WO (1) | WO1999022723A1 (en) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE467340B (en) * | 1990-07-04 | 1992-07-06 | Perstorp Ab | USE OF INOSITOL MONOPHOSPHATE FOR THE PREPARATION OF AN EFFECTIVE EFFECT AS A NEUROPEPTID Y (NPY) ANTAGONIST |
| FR2679229B1 (en) * | 1991-07-16 | 1994-08-05 | Commissariat Energie Atomique | PROCESS FOR THE PREPARATION OF CIS-INOSITOL, MESO-INOSITOL, EPI-INOSITOL AND / OR CIS-QUERCITOL MAY BE DEUTERED. |
| US5998485A (en) * | 1997-06-16 | 1999-12-07 | Cedars-Sinai Medical Center | Method for modulating immune response with inositol |
-
1997
- 1997-10-30 IL IL12207797A patent/IL122077A0/en unknown
-
1998
- 1998-10-29 WO PCT/IL1998/000523 patent/WO1999022723A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999022723A1 (en) | 1999-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP9904525A3 (en) | Pharmaceutical compositions for the treatment of neurological disorders comprising s-(-)-n-propargyl-1-amino indan | |
| IL116998A0 (en) | Novel indoline compounds processes for their preparation and their use for the treatment of CNS disorders | |
| IL138129A (en) | Composition for therapy of estrogen-associated disorders | |
| IL121170A0 (en) | Compositions for the treatment of dermatological disorders | |
| HRP990195B1 (en) | Intranasal formulations for the treatment of sexual disorders | |
| PL348817A1 (en) | Compositions and methods for the treatment of anorectal disorders | |
| HUP0103856A3 (en) | Pharmaceutical composition for the treatment of acute disorders | |
| HUP0101627A3 (en) | Pharmaceutical compositions for treating neuropsychiatric disorders | |
| PL336290A1 (en) | Sulphonamides for treating endothelin-involving disorders | |
| IL141263A0 (en) | Methods for treatment of neurological disorders | |
| HUP0200287A3 (en) | Pharmaceutical compositions for the treatment of neurological or neuropsychiatric disorders | |
| PL341392A1 (en) | Triazinic compounds for treating cns disorders | |
| IL138172A0 (en) | Process for the cis-selective hydrogenation of cyclohexylidenamines | |
| PL345769A1 (en) | Triazolopyridines for the treatment of thrombosis disorders | |
| HRP980097A2 (en) | Combinatory compositions for the treatment of dementia | |
| AU2557895A (en) | Composition for treating gastrointestinal disorders | |
| CZ20011872A3 (en) | Isonipecotamides for the treatment of integrin-mediated disorders | |
| IL122077A0 (en) | Epi-inositol compositions for the treatment of CNS disorders | |
| SG82014A1 (en) | The use of aryl-cyclohexylamine derivatives against cns disorders | |
| EP1053748A4 (en) | Remedies for neurological disorders | |
| IL112223A0 (en) | Pharmaceutical compositions for the treatment of neurological inflammatory conditions | |
| PL343596A1 (en) | Paroxetine 10-camphorsulfonate for treatment of cns disorders | |
| IL131765A0 (en) | Process for the purification of substituted p-nitrodiphenylethers | |
| HK1028609A (en) | Triazine compounds for treatment of cns disorders | |
| AU2245695A (en) | Composition for treating neurological disorders |